AI Health & Biotechnology

New AI Tool YuelDesign Speeds Drug Discovery

University of Virginia researchers use diffusion models to account for protein flexibility in drug development.

By Kronos News Desk··1 min read
A detailed 3D digital model of a protein molecule showing flexibility and movement as part of an AI-driven drug discovery process.

A detailed 3D digital model of a protein molecule showing flexibility and movement as part of an AI-driven drug discovery process.

Photo: Kronos News

Scientists at the University of Virginia School of Medicine have launched YuelDesign, a new AI platform designed to improve drug discovery [1][2]. The tool utilizes advanced diffusion models to design drug molecules that account for the shifting shapes of proteins [1]. This breakthrough addresses a major hurdle in pharmaceutical development where static protein models often cause drugs to fail in clinical trials [1][2]. Protein flexibility is a fundamental aspect of biological interactions that traditional technologies often struggle to replicate [1][3]. By incorporating these dynamic movements, YuelDesign allows researchers to better predict how drugs will interact with targets in real-world conditions [3]. This technology aims to accelerate the timeline for bringing new medicines to market [2][3].

Editorial notes

Transparency note

Drafted with LLM; human-edited

AI assisted
Yes
Human review
Yes
Last updated

Risk assessment

Under review

Reviewed for sourcing quality and editorial consistency.

Sources

Related stories

View all

Topics

Get the weekly briefing

A concise briefing with selected stories and analysis.

No spam. Unsubscribe anytime. By joining, you agree to our Privacy Policy.

About the author

Kronos News Desk covers ai health & biotechnology and editorial analysis for Kronos News.